awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q45301837-621B747E-6F4D-44F7-9629-D1F3F8916C3C
Q45301837-621B747E-6F4D-44F7-9629-D1F3F8916C3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45301837-621B747E-6F4D-44F7-9629-D1F3F8916C3C
Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study.
P2860
Q45301837-621B747E-6F4D-44F7-9629-D1F3F8916C3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45301837-621B747E-6F4D-44F7-9629-D1F3F8916C3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
af826c4578249dba4552c9dca724596d62e4d8f0
P2860
The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for mot